Lab to Lives
A simple question started this show: How do we medicine from the lab to making a difference in people's lives as quickly as possible?
The answers are complex. Actual solutions are hard to come by. We want to distill ideas until we see actual impact in the industry.
Our three hosts all have backgrounds in life sciences and in improv comedy. Together, with their guests, they're on a mission to have conversations that can have an impact. And have some fun along the way.
Lab to Lives
Matt Wilson: Transforming how patients benefit from population level research
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Matt Wilson guests the show and talks to Sam and Ivanna about how automating consent and recruitment processes can broaden the net in terms of the number of patients involved in clinical trials. A broader patient population means that underrepresented groups gain access to clinical trials and allow a much more detailed characterization of an overall patient population.
Removing barriers for patients to participate in trials also means using technology that is most accessible and sometimes low tech - such as the text message. Understanding your population can also help target your communication to specific groups, thereby increasing diversity in the trials participants.
We speak about how Real World Data has evolved from databases over patient populations to electronic patient records and third party companies collecting large data sets. Using electronic health records directly means that the broken link between the actual patient and findings made in population level research is mended, meaning that the patients themselves can benefit directly from the findings in the large-scale studies.
We also speak about the benefits of providing information to the patients about what their data has contributed to, and potentially providing them the benefits of the newly created knowledge.
Matt encourages our industry to pursue open-mindedness to try and engage with new ideas and new ways of doing things. Not everything will work out, but the potential to unlock real value to patients is to great to ignore.
“Patients want to help with research, and it is about providing them the means of doing that in a way that is not burdensome, and allow them to see how they have contributed. “
- Matt Wilson
Notes
- Guest Matt Wilson : https://www.linkedin.com/in/drmattwilson/
- uMed: https://www.umed.io/
- Example mentioned of 23andMe: https://www.23andme.com/en-eu/?evr=epv
- NHS Blood Donation Service: https://www.blood.co.uk/
Visit Labtolives.com
Do you want to try the quiz from this episode? Find the link on our LinkedIn profile: https://www.linkedin.com/company/labtolives/
Would you like to join the show as a guest or collaborator? Find out how on our website: https://www.labtolives.com/
________
Reach out to Ivanna Rosendal
Join the conversation on our LinkedIn page
Hosts
Alexander Booth aka the MedTech Guy
Dimitri Borisevich aka the start-up Guy
Ivanna Rosendal aka the R&D pharma Gal
.png)
